12 research outputs found
Cor triatriatum dexter associated with atrial septal defect : management in a complex clinical case
The coexistence of an atrial septal defect and a prominent eustachian valve is a rare congenital anomaly, rarely reported in literature. Differentiation between a giant eustachian valve and cor triatriatum dexter can be difficult. A case of a large atrial septal defect associated with cor triatriatum dexter diagnosed by echocardiography in an asymptomatic woman is reported. A watchful waiting strategy was adopted
Long-term prognostic value of dobutamine stress echocardiography in diabetic patients with limited exercise capability: A 13-year follow-up study
OBJECTIVE - To determine the incremental prognostic value of dobutamine stress echocardiography (DSE) at 13-year follow-up (SD 3.2 years) for predicting mortality and cardiac events in diabetic patients. RESEARCH DESIGN AND METHODS - A total of 396 diabetic patients (mean age 61 ± 11 years; 252 men [64%]) with limited exercise capacity who underwent DSE for evaluation of ischemia were studied. End points were all causes of mortality, cardiac death, and hard cardiac events (cardiac death and nonfatal myocardial infarction). RESULTS - During a mean follow-up of 13 years, 230 patients (58%) died (121 cardiac deaths), and 30 patients had nonfatal myocardial infarction. Cumulative survival in patients with an abnormal DSE at 5, 10, and 15 years was 68, 49, and 41%, respectively. In patients with a normal DSE, these respective numbers were 74, 57, and 44%. Multivariate analyses showed that DSE provided incremental value over clinical characteristics and stress test parameters for prediction of mortality and cardiac events. Survival analysis showed that DSE provided optimal risk stratification up to 7 years after initial testing; after that period, the risk of adverse outcome increased comparably in both normal and abnormal DSE patients. CONCLUSIONS - DSE provided restricted predictive value of adverse outcome in patients with diabetes who were unable to performan adequate exercise stress test. DSE provided optimal risk stratification up to 7 years after initial testing. Repeated DSE at that time might add to its prognostic value
Pulmonary arterial hypertension in idiopathic myelofibrosis is associated with an altered angiogenic status
Pre-heart failure at 2D- and 3D-speckle tracking echocardiography: A comprehensive review
Chronic heart failure (CHF) has different stages and includes pre-HF (PHF), a state of high risk of developing myocardial dysfunction and advanced CHF. Some major behavioral risk factors of PHF might predispose to biological risk factors such as obesity, diabetes mellitus, dyslipidemia, hypertension, myocardial infarction, and cardiomyopathy. These risk factors damage the myocytes leading to fibrosis, apoptosis, cardiac hypertrophy, along with alterations in cardiomyocyteâ size and shape. A condition of physiological subcellular remodeling resulting into a pathological state might be developed, conducting to PHF. Both PHF and heart failure (HF) are associated with the activation of phospholipases and protease, mitochondrial dysfunction, oxidative stress and development of intra-cellular free Ca2+ [Ca2+]i overloading to an elevation in diastolic [Ca2+]i. Simultaneously, cardiac gene expression is activated leading to further molecular, structural and biochemical changes of the myocardium. The sub-cellular remodeling may be intimately involved in the transition of cardiac hypertrophy to heart failure. 2D- and 3D-speckle tracking echocardiography (STE) have been used to quantify regional alterations of longitudinal strain and area strain, through their polar projection, which permits a further assessment of both sites and degrees of myocardial damage. The examination of strain can identify sub-clinical cardiac dysfunction or cardiomyocyte remodeling. During remodeling of the myocardium cardiac strain is attenuated, therefore it is an indicator of disease assessment
Abdominal Aortic Aneurysm Screening Using a Hand-held Ultrasound Device. âA Pilot Studyâ
Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium
Background: Repeat coronary artery bypass grafting (redo-CABG) in patients with ischaemic cardiomyopathy is associated with high perioperative risk and worse long-term outcome compared with patients undergoing their first CABG. Objective: To assess whether patients with viable myocardium undergoing redo-CABG have a better outcome. Methods: 18 patients with ischaemic cardiomyopathy underwent redo-CABG and 34 underwent their first CABG; all had substantial viability (â„25% of the left ventricle) o
Valore prognostico della coronarografia-TC a 64 strati nei pazienti diabetici con cardiopatia ischemica nota o sospetta a confronto con la popolazione non diabetica
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration. European Respiratory
The European Early Lung Cancer (EUELC) project aims to determine if specific
genetic alterations occurring in lung carcinogenesis are detectable in the respiratory epithelium.
In order to pursue this objective, nonsmall cell lung cancer (NSCLC) patients with a very high risk
of developing progressive lung cancer were recruited from 12 centres in eight European
countries: France, Germany, southern Ireland, Italy, the Netherlands, Poland, Spain and the UK. In
addition, NSCLC patients were followed up every 6 months for 36 months. A European Bronchial
Tissue Bank was set up at the University of Liverpool (Liverpool, UK) to optimise the use of
biological specimens.
The molecularâpathological investigations were subdivided into specific work packages that
were delivered by EUELC Partners. The work packages encompassed mutational analysis,
genetic instability, methylation profiling, expression profiling utilising immunohistochemistry and
chip-based technologies, as well as in-depth analysis of FHIT and RARb genes, the telomerase
catalytic subunit hTERT and genotyping of susceptibility genes in specific pathways.
The EUELC project engendered a tremendous collaborative effort, and it enabled the EUELC
Partners to establish protocols for assessing molecular biomarkers in early lung cancer with the
view to using such biomarkers for early diagnosis and as intermediate end-points in future
chemopreventive programmes